baber/WOPTO huggingface dataset:
Patent MX-PA01001291-A (MX)
Title: Artificial hair for implantation and process for producing the artificial hair.
Inventor: YAMADA SHIRO
Filed: 2001-02-02
Abstract: A monofilament fabricated by a process in which a melt spinning and drawing treatment are carried out after particles of silver ceramics are mixed with a resin material for a fiber having a principal component of polybutylene terephthalate. The particles of the silver ceramics have a size of 5.0 mu m or less, and the content of the particles of the silver ceramics in the mixture is within a range of 0.3% to 3.0%. Then, the surface of the monofilament is subjected to a mechanical delustering treatment, thus obtaining artificial hair having low bacterial infection rate, high fixation rate of implanted hairs, and high durability, such that the hair does not break at a point near the root part even after having been used for a long period of time after implantation.
Patent MX-PA01002163-A (MX)
Title: Catalyst for purifying the exhaust gases of diesel engines, and process for the preparation thereof.
Inventor: RAINER DOMESLE
IPC: F01N3/28
Filed: 2001-02-28
Abstract: A catalyst for purifying the exhaust gases of diesel engines, which catalyst contains at least one zeolite and, additionally, at least one of the support oxides aluminum oxide, silicon dioxide, titanium dioxide and aluminum silicate and at least one of the noble metals platinum, palladium, rhodium and iridium. In this catalyst the atoms of the noble metals have a mean oxidation number of less than +2.5, on average more than 3 metal ligands and less than 3 oxygen ligands and are present on the zeolites and support oxides in the form of crystallites having a mean particle size of from 1 to 6 nm.
Patent MX-PA01002810-A (MX)
Title: Integrated torque motor and throttle body.
Inventor: HATTON BRUCE M
IPC: F02M9/127
Filed: 2001-03-16
Abstract: An electrically operated throttle valve assembly 110, 210 having a throttle shaft 18, 218 with a portion extending exteriorly of the throttle body 12. Rotor 166, 266 is mounted on the extending portion of shaft 18, 218. A housing 80 concentrically surrounds the rotor 166, 266 and includes a rear wall 86, 286 to which stator 134, 234 is attached. The stator 134, 234 having a plurality of circumferentially spaced pole segments each with a coil is mounted to the rear wall 86, 286 and is concentrically disposed within the rotor 166, 266. The hollow cylindrical rotor 166, 266 with plural magnets 72, 74, 272, 274 disposed about the inner periphery has a radial web flange 168, 268 which is drivingly attached to one end of the extending portion of shaft 18, 218 with the rotor 166, 266 nested over the stator pole segments. Reducing the size or even eliminating the mounting shaft or bolt 92, and preferably replacing it with a welded, wound and overmolded stack of laminations provides more windi ng area for electrically conductive coils to provide more magnetic flux.
Patent MX-PA01008720-A (MX)
Title: Earthquake proofing reinforcing metal fitting.
Inventor: TORU IWAKAWA
IPC: E04B1/26
Filed: 2000-01-25
Abstract: An earthquake proofing reinforcing metal fitting (1) of which earthquake proofing performance is more increased than before so that a wooden building is not collapsed even if a strong vibration is applied to it by an earthquake or a typhoon, comprising an L shaped base material (2) formed by bending a plate material and forming inwardly curved extended parts (5a, 5b) at the intermediate parts of both piece parts (2a, 2b), a reinforcing member (3) formed by bending a plate material and brought into contact with the bent part of the L shaped base material (2), and a damping member (4) made of a rubber material excellent in elastic characteristics and water resistance and locked to the L shaped base material (2) at a plurality of positions, wherein, when the reinforcing member (3) is brought into contact with the L shaped base material (2), a clearance (10) is produced between a bent corner part (3c) of the reinforcing member (3) and the bent corner part (2c) of the L shaped base material (2).
Patent MX-PA01008796-A (MX)
Title: Physicochemical process for the treatment of human solid wastes into organic manure.
Inventor: OSCAR ENRIQUE PEREZ TORRES
IPC: C05F3/04
Filed: 2001-08-31
Abstract: The present invention refers to a physicochemical process for the treatment of human solid wastes into organic manure, reducing the contamination or sewage for the technological advances in the field of sanitary installations is focused in reducing the water level of the WC tanks, but above all in introducing treatment plants of residual waters which is very helpful; and if it is possible to remove human wastes from water, these plants would become more efficient if they do not mix with urban, pluvial and industrial wastes. Therefore the invention has the following new characteristics; in the compacting to convert it in a homogeneous mass air-free and physically treated, helped by zeolite, straw, chloride dioxide, paper sheets or the like and rammer; the isolation of fecal matter with disinfectants and dehydrating agents is another important characteristic; the exclusive transportation of semi-dried fecal matter odor-free and disinfected in hermetic depositories; subduing the fecal ma tter to baking without calcinating it; and finally making the conversion or recycling of fecal matter into organic manure.
Patent MX-PA01010345-A (MX)
Title: Foaming cosmetic products.
Inventor: MOHAMMADI FATEMEH
IPC: A61Q19/00
Filed: 1999-12-02
Abstract: A foaming cosmetic product is provided which is packaged within a container fitted with pump and nozzle to express a cosmetic composition in mousse form. Foam may be generated by an agent which is a mechanical device such as a screen within a valve or by an aerosol propellant in a pressurized system. The cosmetic composition includes a crosslinked non-emulsifying polysiloxane elastomer and a carboxyvinyl polymer, the latter stabilizing the composition against separation and contributing to a rich dense foam.
Patent MX-PA01011078-A (MX)
Title: Branched glucose soluble polymers and method for the production thereof.
Inventor: CABOCHE JEAN-JACQUES
IPC: C08B30/12
Filed: 2000-04-26
Abstract: The invention relates to glucose soluble polymers which do not substantially contain any beta glucosidic bonds, characterized in that they comprise 2.5 -10 % alpha-1,6 gluocosidic bonds, have a very low or zero tendency to retrograde in an aqueous solution determined according to a test A, possess an MP which is determined according to a test C having a median value of the distribution profile of the molecular masses ranging from 104 and 105 Daltons and have a reducing sugar content that is at most 9 %.
Patent MX-PA01013095-A (MX)
Title: Multiplier module of the expansion port in hand-held computers.
Inventor: JORGE WEITZNER GELRUD
IPC: H01R/
Filed: 2001-12-18
Abstract: The present invention refers to a multiplier module of the Springboard expansion port (slot) which allows connecting two or three Springboard accessory modules to a single Springboard expansion port, and which allows simulating a multi-tasking environment where the Springboard accessory modules remain simultaneously active, or are actuated in the required order by the user without loosing the utility of the inactive accessory modules. With the latter, it is avoided to replace physically the accessory modules combining their functionalities having a greater utility of the capacities of the visor and the accessory modules.
Patent MX-PA02002486-A (MX)
Title: Use dexrazoxane for treating psoriasis.
Inventor: JADRANKA ROGAN-GRGAS
IPC: A61K31/00
Filed: 2000-09-08
Abstract: The use for the manufacture of a medicament for treating psoriasis of dexrazoxane, the d isomer of 1,2 bis(3,5 dioxopiperazin 1 yl) propane, or a physiologically acceptable salt thereof.
Patent MX-PA02002726-A (MX)
Title: Method and device for mechanically sewing a double chain stitch seam.
Inventor: PETER REINDERS
IPC: D05B61/00
Filed: 2000-12-21
Abstract: The aim of the invention is to provide a method for mechanically locking a double chain stitch seam. The chain stitch is produced by means of an industrial sewing machine comprising a sewing needle and a sewing thread as well as by a main gripper comprising a gripper thread. The sewing direction is reversed for locking purposes. The aim of the invention is also to guarantee that the chain stitch seam is sewn in a simple and very precise manner by means of the inventive method and even when the sewing speed is high. According to the inventive method and after the sewing direction has been reversed, the thread loop which is formed by the sewing needle underneath the web of fabric is received by the main gripper in the stitching rhythm of the sewing needle. The thread loop is subsequently pushed on the main gripper against the working direction thereof by means of an auxiliary component that is driven in a synchronous manner by the sewing machine. The needle thread which forms the thread loop is then joined with the gripper head and held in this position underneath the sewing level at a distance from the needle and the main gripper in front of said needle and gripper and in the forward sewing direction by means of said auxiliary component. The joined thread area is moved in the forward sewing direction and a thread triangle formed by the needle thread rope that forms the loop is stretched in the gripper thread area that extends in parallel in relation to the main gripper and in the gripper thread area that leads to the joined area. The sewing needle stitches into said triangle. The thread triangle is subsequently held open by means of the auxiliary component until the next thread loop of the needle thread is formed. The joined thread area is released by the auxiliary component approximately at the same time.
Patent MX-PA02004368-A (MX)
Title: 1 cyclic amino alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants.
Inventor: KAUSS VALERJANS
IPC: A61K31/40
Filed: 1999-11-01
Abstract: Certain 1 cyclic amino alkylcyclohexanes selected from the group consisting of those of formula (I) wherein R* is (CH2)n (CR6R7)m NR8R9; wherein nplus;m=0,1, or 2; wherein R1 through R7 are independently selected from the group consisting of hydrogen and lower alkyl (1 6c), at least R1, R4, and R5 being lower alkyl, and wherein R8 and R9 together represent lower alkylene (CH2)x wherein x is 2 to 5, inclusive, and enantiomers, optical isomers, hydrates, and pharmaceutically acceptable salts thereof, are systemically active uncompetitive NMDA receptor antagonists and are therefore useful in the alleviation of conditions resulting from disturbances of glutamatergic transmission. More importantly, these compounds exhibit outstanding anticonvulsant and anti seizure activity which is not shared by closely related noncyclic amino compounds. Pharmaceutical compositions thereof and a method of treating conditions which are alleviated by the employment of the same, especially the alleviation of convulsions and seizures, and method for the preparation of the active 1 cyclic amino alkylcyclohexane compounds involved and the manufacture of medicaments therefrom.
Patent MX-PA02008102-A (MX)
Title: Synergistic activation of regulatory elements by rel proteins and a steroid receptor.
Inventor: BOERSMA CHRISTINE J C
IPC: C12N15/09
Filed: 2001-03-06
Abstract: Interaction of Rel proteins and steroid receptors is known to result in repression of target genes. Here we describe the discovery of a new mechanism in which Rel proteins and steroid receptors act synergistically to activate a regulatory element. This mechanism is shown to influence the expression of the brain specific 5HT1A receptor wherein the estrogen receptor acts synergistically with the Nuclear Factor kappa B to enhance the activity of the promoter for the 5HT1A receptor gene. In addition, synergistic effects of Rel proteins with the mineralocorticoid receptor were observed, showing that synergism with Rel proteins may be expected for other steroid receptors as well. The synergism between Rel proteins and estrogen receptor or mineralocorticoid receptor provides a tool for the development of compounds that interact with the estrogen or mineralocorticoid receptor in such a way that only the synergistic effect is modulated whereas other effects are left intact. Such compounds would be invaluable for the development of medicaments for the treatment of diseases of the central nervous or cardiovascular system and other disorders in which Rel proteins play a role.
Patent MX-PA02008382-A (MX)
Title: Refrigeration appliance with vacuum insulation.
Inventor: PICOZZI ANDREA
IPC: F25D21/04
Filed: 2002-08-28
Abstract: A domestic refrigeration appliance, such as a refrigerator, freezer or the like, comprising a door and with vacuum heat insulation interposed between a substantially vacuum-tight inner shell and a substantially vacuum-tight outer shell; the two shells (3, 4, 3', 4'; 3A, 4A) are joined together vacuum-tight on that side towards the door (P) by means of a flange-like extension (6, 6', 6A) provided on one of said shells and welded vacuum-tight to the other shell.
Patent MX-PA02010311-A (MX)
Title: Solid dispersion with improved absorbability.
Inventor: SHIMOJO FUMIO
IPC: A61K9/10
Filed: 2001-04-05
Abstract: A solid dispersion which comprises a polymeric carrier and either a compound (I) represented by the formula (I) or a salt thereof. Thus, the compound (I) and its salt, which are sparingly water soluble, can have improved oral absorbability.
Patent MX-PA03000750-A (MX)
Title: Elongase genes and uses thereof.
Inventor: MUKERJI PRADIP
IPC: A23L33/00
Filed: 2001-07-24
Abstract: The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated acids (i.e., elongases) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of DGLA or 20:4n-3 to eicosapentaenoic acid (EPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, w6-docosapentaenoic acid or w3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.
Patent MX-PA03000784-A (MX)
Title: Method for preventing and curing diseases of an immune system and a remedy for carrying out said method.
Inventor: BRITOV VASILY ALEXANDROVICH
IPC: A61K35/62
Filed: 2001-06-25
Abstract: The invention relates to medicine, in particular to methods and remedies for preventing and curing diseases of a human being and an animal, whereby said diseases are associated with a malfunction of the immune system, such as, for example, cancer of the first and second stages and of various localisations or AIDS-infection. The aim of the invention is to increase the efficiency of preventing and curing the immune system of the human being and animal, and to produce active and stable cellular immunity with respect to these diseases. The inventive method for preventing and curing the diseases of the immune system consists in an oral dose of a drug whose a main ingredient contains from 1000 to 6000 alive larvae of the 1895 class of Trichinella Railliet nematodes, which is specially raised. Said larvae has reduced pathogenic and strong immunogenic properties. The animals infected with the larvae have an easier reconvalescence, and recontamination prevents the disease. The usual therapeutic correction, like for trichinosis, is carried out after the administration of the preparation. The reutilization of the preparation is carried out not later than after two months.
Patent MX-PA03003207-A (MX)
Title: MATERIALS AND METHODS TO MODULATE LIGAND BINDING/ENZYMATIC ACTIVITY OF agr;/bgr; PROTEINS CONTAINING AN ALLOSTERIC REGULATORY SITE.
Inventor: STAUTON DONALD E
IPC: A61K31/4545
Filed: 2001-10-12
Abstract: Methods of modulating binding between an agr;/bgr; protein and a binding partner are provided, along with methods of identifying modulators and their use.
Patent MX-PA03005536-A (MX)
Title: A catalyst composition and method for its preparation and use in a polymerization process.
Inventor: STEVEN K ACKERMAN
IPC: C08F2/34
Filed: 2001-11-16
Abstract: The present invention relates to a catalyst composition and a method for making the catalyst composition which comprises a polymerization catalyst and at least one gelling agent. The invention is also directed to the use of the catalyst composition in the polymerization of olefin(s). In particular, the polymerization catalyst system is supported on a carrier.
Patent MX-PA03008539-A (MX)
Title: Antitumor compositions containing taxane derivatives.
Inventor: MARIE-CHRISTINE BISSERY
IPC: A61K33/243
Filed: 2002-03-21
Abstract: A pharmaceutical composition comprised of acetocyclorpropyl taxotere or a derivative thereof, and at least one of an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, and enzyme, a topoisomerase inhibitor, a plantinum coordination complex, a biological response modifier or a growth factor inhibitor is described.
Patent MX-PA04000790-A (MX)
Title: Soft polyolefin compositions.
Inventor: ANTEO PELLICONI
IPC: C08F10/00
Filed: 2002-04-08
Abstract: A polyolefin composition comprising: (A) from 8 to 25% by weight of a crystalline homopolymer or copolymer of propylene: (B) from 75 to 92% by weight of an elastomeric fraction comprising: (1) a first elastomeric copolymer of propylene with from 15 to 32% by weight at least one alpha-olefin of formula H2C=CHR, where R is H or a C2-6 linear or branched alkyl, optionally containing 0.5 to 5% by weight of a diene, said first elastomeric copolymer containing alpha-olefin, and having solubility in xylene at room temperature greater than 50% by weight, the intrinsic viscosity of the xylene soluble fraction ranging from 3.0 to 5.0 dl/g; and (2) a second elastomeric copolymer of propylene with at least one alpha-olefin of formula H2C=CHR, where R is H or a C2-6 linear or branched alkyl, optionally containing 0.5 to 5% by weight of a diene, said second elastomeric copolymer containing more than 32% up to 45% by weight alpha-olefin, and having solubility in xylene at room temperature greater than 80% by weight, the intrinsic viscosity of the xylene soluble fraction ranging from 4.0 to 6.5 dl/g; the (1)/(2) weight ratio ranging from 1:5 to 5:1.
Patent MX-PA04000889-A (MX)
Title: Crystalline forms vi and vii of atorvastatin calcium.
Inventor: M SATYANARAYANA REDDY
IPC: A61K31/40
Filed: 2002-01-07
Abstract: The present invention relates to novel crystalline forms of atorvastatin calcium and to the methods of their production and isolation. More specifically, the present invention relates to novel Forms VI and VII of R-(R*, R*)]-2 (4-fluorophenyl) -B, d dihydroxy -5(1-methylethyl) -3-phenyl -4-[(phenylamino) carbonyl]-1 -H-pyrrole-1 -heptanoic- acid calcium salt and hydrates thereof and to methods of their preparation.
Patent MX-PA04001993-A (MX)
Title: Crankshaft damper with integral pulse ring and method for production.
Inventor: YAHYA HODJAT
IPC: B21H1/04
Filed: 2002-07-30
Abstract: The invention comprises a crankshaft damper (100) having an integral pulse ring (17). The crankshaft damper comprises an inner hub (110) and outer pulley (15) with an elastomeric connecting member (14) between each. The elastomeric ring dampens a crankshaft vibration. The integral pulse ring is manufactured as part of the inner hub by flow forming a sheet metal blank.
Patent MX-PA04002837-A (MX)
Title: Recombinant anti-osteopontin antibody and use thereof.
Inventor: HIROAKI MAEDA
IPC: C07K16/18
Filed: 2002-09-25
Abstract: A recombinant antibody in which at least the constant regions in the heavy chain and the light chain have been converted into human-origin regions and which inhibits the binding of an integrin recognizing the RGD sequence to osteopontin or its fragment and inhibits the binding of an integrin recognizing the SVVYGLR sequence or a sequence corresponding thereto to osteopontin or its fragment. This antibody is useful as a remedy for autoimmune diseases and a remedy for rheumatism or rheumatoid arthritis. Thus, a method of treating autoimmune diseases, rheumatism or rheumatoid arthritis is provided. This osteopontin antibody is useful in a diagnostic for rheumatism and a method of diagnosing rheumatism too.
Patent MX-PA04003564-A (MX)
Title: Photoactivable nitrogen bases.
Inventor: TUNJA JUNG
IPC: C07D519/00
Filed: 2002-10-08
Abstract: Compounds of the formula I R7"N-R6 RS-C,N-R4 H C, R'/ I R, 3 R 2 (I) in which R, is an aromatic or heteroaromatic radical which is capable of absorbing light in the wave-length range from 200 nm to 650 nm and which is unsubstituted or substituted one or more times by C,-C,8alkyl, C2-C,ealkenyl, C2-C,8alkynyl, C,-C,ehaloalkyl, N02, NR,OR , CN, OR,2, SR,2, C(O)R,3, C(O)OR,4, halogen or a radical of the formula II R~-N' R6 1 R5-C,N.R4 H I C - R3 I R2 (II) and which on absorption brings about a photoelimination which leads to the generation of an amidine group, R2 and R3 independently of one another are hydrogen, C,-C,ealkyl or phenyl which is unsubstituted or is substituted one or more times by C,-C,8alkyl, CN, OR,2, SR,2, halogen or C,-C,ehaloalkyl; R5 is C,-C,ealkyl or NR8R9; R4, R6, R, R8, R9, R,o and R inde-pendently of one another are hydrogen or C,-C,8alkyl; or R4 and R6 together form a C2-C,2alkylene bridge which is unsubstituted or is substituted by one or more C1-C4alkyl radicals; or R5 and R,, independently of R4 and R6, together form a C2-C,2alkylene bridge which is unsubstituted or is substituted by one or more C1-C4alkyl radicals; or, if R5 is a radi-cal NR8R9, R, and R9 together form a C2-C,2alkylene bridge which is unsubstituted or is sub-stituted by one or more C1-C4alkyl radicals; and R,2, R,3 and R,4 independently of one another are hydrogen or C,-C,ealkyl; are suitable as photoinitiators for compounds which react under base catalysis.
Patent MX-PA04004278-A (MX)
Title: Modulating urea degradation in wine yeast.
Inventor: INGLIS DEBRA
IPC: C12N9/80
Filed: 2002-11-06
Abstract: The invention provides yeast strains transformed to reduce nitrogen catabolite repression of a gene encoding a urea degrading enzymatic activity expressed by the yeast strain under fermenting conditions. Strains ofSaccharomyces cerevisiae are for example provided having enhanced DUR1,2 urea carboxylase-allophanate hydrolase activity under wine fermenting conditions.
Patent MX-PA04004968-A (MX)
Title: Hydraulic formed body.
Inventor: YOSHINORI HITOMI
IPC: D21H27/28
Filed: 2004-05-25
Abstract: PROBLEM TO BE SOLVED: To provide a hydraulic formed body in which cost occupied by reinforcing fiber can be made lower in a manufactured sheet as a building material particularly useful as a substitute for asbestos while sufficiently securing its reinforcing properties. SOLUTION: The hydraulic formed body comprises reinforcing fiber consisting of mixed fiber between an organic fiber group A and an organic fiber group B, and in which, as for affinity to cement, the organic fiber group A>the organic fiber group B is satisfied, also, the fiber mixing ratio between the organic fiber group A and the organic fiber group B in the mixed fiber satisfies 70/30 to 10/90, and the average fiber strength of the mixed fiber obtained by following expression is >=6.5cN/dtex: <<the average fiber strength>>=<<the fiber strength of the A group>>*X+<<the fiber strength of the B group>>*Y, wherein, X is the fiber mixing ratio of the organic fiber group A; Y is the fiber mixing ratio of the organic fiber gr oup B; and X+Y=1 is satisfied.